The Utility of feNO in the Differential Diagnosis of Chronic Cough
Status:
Completed
Trial end date:
2017-03-09
Target enrollment:
Participant gender:
Summary
In this study the investigators wish to explore the difference in 24 hr. cough counts
measured using the Hull Automated Cough Counter (HACC), from baseline and after two weeks
treatment with either montelukast or prednisolone in patients with an NO measurement of ≥30
ppb at screening.
Phase:
Phase 4
Details
Lead Sponsor:
Hull and East Yorkshire Hospitals NHS Trust Hull University Teaching Hospitals NHS Trust